Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT05773300
  4. Details
NCT05773300 Clinical Trial

Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

Healthy Clinical Trial

Official title:
Control Population for the Mayo Clinic Adult Congenital Heart Disease Registry

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05773300
Other study ID # 21-011938
Secondary ID R01HL158517
Status Recruiting
Phase
First received
Last updated
Start date January 6, 2022
Est. completion date December 2025

Study information
Verified date March 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Recruitment information / eligibility
Status Recruiting
Enrollment 75
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - BMI = 30. - No current cardiac medications. - Systolic BP = 140 mmHg. - Diastolic BP = 90 mmHg. - Capacity to consent. Exclusion Criteria: - To be assessed via EMR screening. - Patient confirmation during screening visit. - Screening tests as applicable. - History of cardiovascular disease. eGFR < 30. - Current orthopedic limitations.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Mayo Clinic Minnesota Rochester Minnesota

Sponsors (3)
Lead Sponsor Collaborator
Mayo Clinic National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Peak Oxygen Uptake Peak Oxygen Uptake (L/min) : 1.7 ± 0.1 6 Months
Primary Peak Right Ventricular - Pulmonary Coupling Peak Right Ventricular - Pulmonary Coupling: (|%|/mmHg): 0.786 ± 0.065 6 Months
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1